-- 根據 Euroz Hartleys 週三發布的一份報告顯示,Duratec(ASX:DUR)透過其與 Ertech 各佔 50% 股份的合資企業,在西澳大利亞的 HMAS Stirling 基地獲得了一份價值 2.81 億澳元的國防基礎設施合約。此舉增強了 Duratec 的訂單可見性,並鞏固了其在 AUKUS 潛艇相關基礎設施交付領域的地位。 該合約將對花園島的 Diamantina 碼頭進行升級改造,使其具備 AUKUS 潛艇的作業能力。在前期投入 1,400 萬澳元後,總投資額將略低於 3 億澳元。從早期承包商參與 (ECI) 到全面竣工,預計交付週期約為 24 個月。 Duratec 表示,此次中標是一項重要的國防合同,驗證了其以早期承包商參與為主導的交付模式,提高了未來兩年的訂單可見性,並增強了其在國防基礎設施領域的佈局,從而支持其中期盈利增長。 該公司將此次中標視為積極的催化劑,增強了其對全年強勁項目儲備的信心,並證明了公司將機會轉化為合約的能力。公司在多個州擁有大量基礎設施和外牆工程項目。 Euroz Hartleys維持對Duratec的「買入」評級,並將目標價從2.57澳元上調至3.09澳元。
Related Articles
Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy Says Australian Retirement Trust Raises Stake
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.